GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 2 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,171,000 | +120.8% | 46,558 | +3.6% | 0.01% | +150.0% |
| Q2 2022 | $1,436,000 | -4.8% | 44,947 | +3.2% | 0.00% | 0.0% |
| Q1 2022 | $1,509,000 | +19.7% | 43,552 | +1.1% | 0.00% | +100.0% |
| Q4 2021 | $1,261,000 | +14.5% | 43,070 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $1,101,000 | -39.1% | 43,214 | -16.3% | 0.00% | -50.0% |
| Q2 2021 | $1,807,000 | -31.6% | 51,600 | -20.4% | 0.00% | -33.3% |
| Q1 2021 | $2,641,000 | -19.6% | 64,800 | -14.5% | 0.00% | -25.0% |
| Q4 2020 | $3,283,000 | -36.1% | 75,800 | -18.7% | 0.00% | -33.3% |
| Q3 2020 | $5,140,000 | -12.1% | 93,226 | +0.6% | 0.01% | -14.3% |
| Q2 2020 | $5,847,000 | +90.2% | 92,626 | +54.0% | 0.01% | +40.0% |
| Q1 2020 | $3,074,000 | -36.7% | 60,159 | -1.6% | 0.01% | -16.7% |
| Q4 2019 | $4,860,000 | +51.9% | 61,142 | -7.3% | 0.01% | +50.0% |
| Q3 2019 | $3,199,000 | -7.1% | 65,927 | +0.7% | 0.00% | 0.0% |
| Q2 2019 | $3,444,000 | +6.7% | 65,468 | +7.4% | 0.00% | 0.0% |
| Q1 2019 | $3,227,000 | +60.5% | 60,968 | +24.4% | 0.00% | +33.3% |
| Q4 2018 | $2,011,000 | -13.9% | 49,000 | -20.3% | 0.00% | 0.0% |
| Q3 2018 | $2,336,000 | -15.9% | 61,478 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,779,000 | +20.5% | 61,478 | +28.7% | 0.00% | 0.0% |
| Q1 2018 | $2,307,000 | +28.1% | 47,758 | +4.4% | 0.00% | +50.0% |
| Q4 2017 | $1,801,000 | +46.9% | 45,758 | +15.8% | 0.00% | 0.0% |
| Q3 2017 | $1,226,000 | +13.5% | 39,500 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $1,080,000 | +50.4% | 39,500 | +102.7% | 0.00% | 0.0% |
| Q1 2017 | $718,000 | +145.9% | 19,488 | -3.5% | 0.00% | – |
| Q4 2016 | $292,000 | -37.3% | 20,200 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $466,000 | +95.0% | 20,200 | +40.3% | 0.00% | – |
| Q2 2016 | $239,000 | +109.6% | 14,400 | +100.0% | 0.00% | – |
| Q1 2016 | $114,000 | -51.1% | 7,200 | 0.0% | 0.00% | – |
| Q4 2015 | $233,000 | – | 7,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |